- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BioInvent International AB (BINV)Assess today's live BioInvent International AB (BINV) share price, performance and insights using our live Stockholm: BINV stock exchange data.
Analyse the historical data and BioInvent International AB share price performance charts on this page. Our technical summary section provides analysis on BioInvent International share price buy/sell indicators using real-time data (or discuss the BioInvent International (BINV) stock price today with other investors in the BioInvent International ST share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ST BINV share price (ISIN: SE0015244520) to enhance your trading decisions with our free investment tools and resources.
What Is the BioInvent International AB Share Price Today?
The BioInvent International share price today is 43.850.
What Is the Stock Symbol for BioInvent International AB
The stock symbol (or 'ticker') for BioInvent International AB is "BINV."
What Stock Exchange Does BioInvent International AB Trade On?
BioInvent International AB is listed and trades on the Stockholm stock exchange.
Is BioInvent International AB a Good Stock to Buy?
Determining whether BioInvent International AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and BioInvent International AB share price performance charts on this page. Our technical summary section provides analysis on BioInvent International share price buy/sell indicators using real-time data (or discuss the BioInvent International (BINV) stock price today with other investors in the BioInvent International ST share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ST BINV share price (ISIN: SE0015244520) to enhance your trading decisions with our free investment tools and resources.
What Is the BioInvent International AB Share Price Today?
The BioInvent International share price today is 43.850.
What Is the Stock Symbol for BioInvent International AB
The stock symbol (or 'ticker') for BioInvent International AB is "BINV."
What Stock Exchange Does BioInvent International AB Trade On?
BioInvent International AB is listed and trades on the Stockholm stock exchange.
Is BioInvent International AB a Good Stock to Buy?
Determining whether BioInvent International AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Stockholm
Currency in SEK
43.850
-0.050(-0.11%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
43.050
44.100
52 wk Range
15.000
50.800
BINV Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
43.05044.100
52 wk Range
15.00050.800
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBINV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Price Target
90.000
Upside
+105.245%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
BioInvent International Company Profile
BioInvent International AB (publ), a clinical-stage company, discovers, researches, and develops novel immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally. Its drug candidates are BI-1808 is in phase 2 clinical trial and BI-1910 in phase 1 clinical trial for solid tumors targeting Tumor necrosis factor receptor-2 (TNFR2); BI-1206/rituximab in phase 2 clinical trial for the treatment of non-Hodgkin’s lymphoma; BI-1206/pembrolizumab and BI-1607/trastuzumab in phase 1 clinical trial to treat solid tumors targeting FCYRIIB; and BT-001 in phase 1 clinical trial for the treatment of solid tumors targeting Cytotoxic T lymphocyte-associated protein-4. The company has a partnership and collaboration with Transgene to develop BT-001 oncolytic viruses for treatment of solid tumors; and collaboration and supply agreement with Merck to evaluate BI-1206, BI-1808, and BT-001 in combination with Keytruda; and licensing agreement with CASI pharmaceuticals for BI-1206. The company was incorporated in 1996 and is based in Lund, Sweden.
Compare BINV to Peers and Sector
Metrics to compare | BINV | Peers Peers - average of corresponding metrics from companies closely matching BINV: ALZ, EXPRS2, LPGO, CRNOSb_old, NXTCL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBINVPeersSector |
|---|---|---|---|---|
P/E Ratio | −7.0x | −2.0x | −0.6x | |
PEG Ratio | 0.23 | −0.04 | 0.00 | |
Price/Book | 2.9x | 1.3x | 2.6x | |
Price / LTM Sales | 74.7x | 9.4x | 3.2x | |
Upside (Analyst Target) | 105.2% | 84.0% | 44.6% | |
Fair Value Upside | Unlock | 24.0% | 7.3% | Unlock |
Analysts' Recommendations
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 90.000
(+105.25% Upside)
People Also Watch
FAQ
What Is the BioInvent International (BINV) Stock Price Today?
The BioInvent International stock price today is 43.85
What Stock Exchange Does BioInvent International Trade On?
BioInvent International is listed and trades on the Stockholm stock exchange.
What Is the Stock Symbol for BioInvent International?
The stock symbol for BioInvent International is "BINV."
What Is the BioInvent International Market Cap?
As of today, BioInvent International market cap is 2.89B.
What is BioInvent International Earnings Per Share?
The BioInvent International EPS is -6.22.
What Is the Next BioInvent International Earnings Date?
BioInvent International will release its next earnings report on 27 Feb 2025.
From a Technical Analysis Perspective, Is BINV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.